BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25857225)

  • 1. JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity.
    Okuma C; Ohta T; Tadaki H; Hamada H; Oda T; Taniuchi H; Yamanaka K; Ishii Y; Ohe Y; Yata S; Nishiu J; Aratsu Y; Oshida S; Kume S; Kakutani M
    Eur J Pharmacol; 2015 Jul; 758():72-81. PubMed ID: 25857225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis.
    Okuma C; Ohta T; Tadaki H; Ishigure T; Sakata S; Taniuchi H; Sano R; Hamada H; Kume S; Nishiu J; Kakutani M
    J Pharmacol Sci; 2015 Jul; 128(3):150-7. PubMed ID: 26215699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of MGAT2 modulates fat-induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high-fat diet.
    Mochida T; Take K; Maki T; Nakakariya M; Adachi R; Sato K; Kitazaki T; Takekawa S
    FEBS Open Bio; 2020 Mar; 10(3):316-326. PubMed ID: 31837122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice.
    Tsuchida T; Fukuda S; Aoyama H; Taniuchi N; Ishihara T; Ohashi N; Sato H; Wakimoto K; Shiotani M; Oku A
    Lipids Health Dis; 2012 Jun; 11():75. PubMed ID: 22698140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestine-specific deletion of acyl-CoA:monoacylglycerol acyltransferase (MGAT) 2 protects mice from diet-induced obesity and glucose intolerance.
    Nelson DW; Gao Y; Yen MI; Yen CL
    J Biol Chem; 2014 Jun; 289(25):17338-49. PubMed ID: 24784138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset deficiency of acyl CoA:monoacylglycerol acyltransferase 2 protects mice from diet-induced obesity and glucose intolerance.
    Banh T; Nelson DW; Gao Y; Huang TN; Yen MI; Yen CL
    J Lipid Res; 2015 Feb; 56(2):379-89. PubMed ID: 25535286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat Utilization.
    Take K; Mochida T; Maki T; Satomi Y; Hirayama M; Nakakariya M; Amano N; Adachi R; Sato K; Kitazaki T; Takekawa S
    PLoS One; 2016; 11(3):e0150976. PubMed ID: 26938273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A predominant role of acyl-CoA:monoacylglycerol acyltransferase-2 in dietary fat absorption implicated by tissue distribution, subcellular localization, and up-regulation by high fat diet.
    Cao J; Hawkins E; Brozinick J; Liu X; Zhang H; Burn P; Shi Y
    J Biol Chem; 2004 Apr; 279(18):18878-86. PubMed ID: 14966132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretin receptor-knockout mice are resistant to high-fat diet-induced obesity and exhibit impaired intestinal lipid absorption.
    Sekar R; Chow BK
    FASEB J; 2014 Aug; 28(8):3494-505. PubMed ID: 24769669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine.
    Yen CL; Farese RV
    J Biol Chem; 2003 May; 278(20):18532-7. PubMed ID: 12621063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of diet-induced obesity by dietary isomerized hop extract containing isohumulones, in rodents.
    Yajima H; Noguchi T; Ikeshima E; Shiraki M; Kanaya T; Tsuboyama-Kasaoka N; Ezaki O; Oikawa S; Kondo K
    Int J Obes (Lond); 2005 Aug; 29(8):991-7. PubMed ID: 15852044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding.
    Yen CL; Cheong ML; Grueter C; Zhou P; Moriwaki J; Wong JS; Hubbard B; Marmor S; Farese RV
    Nat Med; 2009 Apr; 15(4):442-6. PubMed ID: 19287392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of the mouse intestinal acyl-CoA:monoacylglycerol acyltransferase, MGAT2.
    Cao J; Burn P; Shi Y
    J Biol Chem; 2003 Jul; 278(28):25657-63. PubMed ID: 12730219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
    Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
    Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triphala and its constituents ameliorate visceral adiposity from a high-fat diet in mice with diet-induced obesity.
    Gurjar S; Pal A; Kapur S
    Altern Ther Health Med; 2012; 18(6):38-45. PubMed ID: 23251942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
    Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice.
    Hall AM; Soufi N; Chambers KT; Chen Z; Schweitzer GG; McCommis KS; Erion DM; Graham MJ; Su X; Finck BN
    Diabetes; 2014 Jul; 63(7):2284-96. PubMed ID: 24595352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phellinus baumii extract reduces obesity in high-fat diet-fed mice and absorption of triglyceride in lipid-loaded mice.
    Noh JR; Lee IK; Ly SY; Yang KJ; Gang GT; Kim YH; Hwang JH; Yun BS; Lee CH
    J Med Food; 2011 Mar; 14(3):209-18. PubMed ID: 21332399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut carbohydrate metabolism instead of fat metabolism regulated by gut microbes mediates high-fat diet-induced obesity.
    Li M; Gu D; Xu N; Lei F; Du L; Zhang Y; Xie W
    Benef Microbes; 2014 Sep; 5(3):335-44. PubMed ID: 24675232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.